{"database": "lobbying", "table": "lobbying_activities", "rows": [[960305, "4657efed-4f99-4c23-a1a7-46b0c5bf262b", "Q2", "EISAI INC.", 400321512, "EISAI INC.", 2010, "second_quarter", "PHA", "biosimilars, follow-on biologics\nS 726 Promoting Innovation and Access to Life-Saving Medicine Act\nHR 3590 Patient Protection and Affordable Care Act\nHR 4872 Health Care and Education Reconciliation Act of 2010", "HOUSE OF REPRESENTATIVES,SENATE", null, 1060000, 0, 0, "2010-07-19T09:07:45.277000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["960305"], "units": {}, "query_ms": 1.1848959838971496, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}